← All companies

Biocartesian

Active

Converting biology into digital molecular maps

S24·Summer 2024·Healthcare·Philadelphia, PA, USA·Team of 2·Founded 2023

About

Finding new cures requires seeing what and where the abnormal molecules are in a diseased tissue, but current tools see less than 1% of those molecules. Biocartesian combines microscopy and new chemistries to see 50X more, offering unprecedented insights into disease biology and new therapies.

Founders

  • Ian Dardani· Founder/CEO

    Co-founder of Biocartesian. Microscopy + molecular tools + engineering. Previously Bioscience Enterprise at Cambridge, Bioengineering PhD at UPenn.

  • Jess Li· Founder

    Co-founder of Biocartesian. Genetics + epigenetics, next-gen sequencing. Previously PhD at UPenn, BD at imvaria.

Product launches · 1 launch

Change history · 14 recorded

  1. August 30, 2026
    • Founder profile updated08:00 PM
    • Launches refreshed08:00 PM
  2. August 16, 2026
    • Launches refreshed08:01 PM
    • Founder profile updated08:01 PM
  3. July 26, 2026
    • Relocated to Philadelphia08:01 PM
    • Founder profile updated08:01 PM
    • Launches refreshed08:01 PM
    • Location updated07:00 PM
  4. July 12, 2026
    • Launches refreshed08:01 PM
    • Founder profile updated08:01 PM
  5. June 28, 2026
    • Launches refreshed08:01 PM
    • Founder profile updated08:01 PM
  6. June 14, 2026
    • Founder profile updated08:01 PM
    • Launches refreshed08:01 PM